Clinical Trial Update: Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety of azilsartan medoxomil with chlorthalidone versus olmesartan medoxomil with hydrochlorothiazide in adults with hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Benicar (olmesartan medoxomil) (Olmesartan medoxomil)
• Chlorthalidone (chlorthalidone)
• Edarbi (azilsartan medoxomil) (Azilsartan medoxomil)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Takeda | Conditions: Safety | Phase 3 | Status: COMPLETED | Results posted: 2013-12-13